title: Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients.
abstract: Protein energy undernutrition (PEU) and abnormalities of amino acid (AA) metabolism are common in maintenance hemodialysis patients (MHP). A new EAA formulation (BS695), enriched with valine and threonine, containing some histidine, and low in phenylalanine and methionine was recently developed. We randomly supplemented 11 MHP with this solution (treated group, TG) and 10 MHP with a standard AA solution containing both essential and non-essential AA (control group, CG). Both groups received 3.65 g of nitrogen, i.v. three times per week during hemodialysis for six months. During treatment, dietary intake remained stable in both groups. Before treatment, after three and six months of treatment, and six months after the end of treatment, we determined routine blood chemistries, anthropometry, serum protein levels (albumin, transferrin), delayed cutaneous sensitivity (Multi-test), protein catabolic rate (PCR), plasma AA content and motor nerve conduction velocity (MNCV). Before treatment PEU, predominantly of marasmic type, was common. After treatment anthropometry and immune response were unchanged in both groups; PCR increased more in CG than in TG; serum albumin levels decreased significantly only in CG; MNCV improved in TG and worsened in CG. These preliminary results suggest that this new EAA formulation may have beneficial effects on some nutrition related abnormalities of MHP. Better results might occur with long-term AA supplementation, particularly if it is associated with a higher energy intake.
authors.affiliation: Institute of Medical Pathology, University of Trieste, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Toigo
authors.forename: R
authors.initials: R
authors.lastname: Situlin
authors.forename: G
authors.initials: G
authors.lastname: Tamaro
authors.forename: A
authors.initials: A
authors.lastname: Del Bianco
authors.forename: V
authors.initials: V
authors.lastname: Giuliani
authors.forename: F
authors.initials: F
authors.lastname: Dardi
authors.forename: S
authors.initials: S
authors.lastname: Vianello
authors.forename: P
authors.initials: P
authors.lastname: Toffoletto
authors.forename: L
authors.initials: L
authors.lastname: Faccini
authors.forename: G
authors.initials: G
authors.lastname: Guarnieri
mesh_terms: D000601:Amino Acids, Essential / Q000627:therapeutic use*; D004044:Dietary Proteins / Q000032:analysis; D002149:Energy Intake; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D011506:Proteins / Q000378:metabolism; D006435:Renal Dialysis; D012709:Serum Albumin / Q000378:metabolism; D014511:Uremia / Q000378:metabolism / Q000628:therapy
chemical_list: D000601:Amino Acids, Essential; D004044:Dietary Proteins; D011506:Proteins; D012709:Serum Albumin